Embed Size (px)
Citation preview
DAFTAR PUSTAKA
1. Leong, D. Cor Pulmonale: Overview of Cor Pulmonale Management. 2016.
Diunduh dari : http://emedicine.medscape.com/article/154062-overview,
tanggal 14 April 2016 jam 22.30
2. Harun S, Ika PW. Kor Pulmonal Kronik. Dalam Buku Ajar I lmu Penyakit
Dalam, Ed 4. Jakarta. Pusat Penerbitan Departemen Ilmu Penyakit Dalam
Fakultas Kedokteran Universitas Indonesia. 2006; 1680-81
3. Mann, DL. Chapter 227: Heart Disease and Cor Pulmonale. Dalam : Fauci,
AS et al. Harrison’s Principles of Internal Medicine. 2008. USA : McGraw-
Hill Companies,IncWeitzenblum E. Chronic Cor Pulmonale. Heart. 2003.
89:225-30
4. Dines DE, Parkin TW. Some Observation on the Value of the
Electrocardiogram in Patient with Chronic CorPulmonale. Mayo Clinic-Proc
2005; 40: 745-750
5. Han MK et al. Pulmonary disease and the heart. Medscape. 2007;116(25):
2992-3005. Available at http://www.medscape.com/medline/abstract/
18086941
6. Isselbacher KJ, et al. Harrison Prinsip-Prinsip Ilmu Penyakit Dalam. Vol 3.
Edisi ke-3.Jakarta: EGC.2000.
7. Shujaat, A, R Minkin, E Eden. Pulmonary Hypertension and Chronic Cor
Pulmonale in COPD. International Journal of COPD. 2007. 2(3):273-282.
8. National Pulmonary Hypertension Centres of the UK and Ireland. Consensus
statement on the management of Pulmonary Hypertension in Clinical Practice
in the UK and Ireland. Heart. 2008. 94(Suppl I): i1-i41.
9. The Joint Task Force for the Diagnosis and Treatment of Pulmonary
Hypertension of the European Society of Cardiology (ESC) and the European
Respiratory Society (ERS). 2015 ESC/ERS Guidelines for the diagnosis and
treatment of pulmonary hypertension. European Heart Journal. 2016. 37:67-
119
10. Sudoyo AW. Buku Ajar Ilmu Penyakit Dalam. Jilid 1. Edisi ke-5. Jakarta:
Interna Publishing
11. Anderson JR, Nawarskas JJ. Pharmacotheurapetic management of pulmonary
arterial hypertension. Medscape. 2010;18(3): 148-162. Available at
http://www.medscape.com/medline/abstract/20395700
12. Mekontso DA et al. Prevalence and prognosis of shunting across patent
foramen ovale during acute respiratory distress syndrome. Medscape.
2010;38(9): 1786-1792. Available at http://www.medscape.com/medline/
abstract/20601861
13. Price SA, Wilson LM. Patofisiologi Konsep Klinis Proses-Proses Penyakit.
Vol 3.2005. Jakarta:EGC.
14. Fedullo PF et al. Chronic thrombo embolic pulmonary hypertension.
Medscape. 2001;345(20): 1465-1472. Available at
http://www.medscape.com/ medline/abstract/11794196
15. Hoeper MM. Drug treatment of pulmonary arterial hypertension : current and
future agents. Medscape. 2005;65(10): 1337-1354. Available at
http://www.medscape.com/medline/abstract/15977967
16. Haeck, MLA, HW Vliegen. Diagnosis and Treatment of Pulmonary
Hypertension. Heart, 2014.0:1-9
17. Sitbon O et al. Long term response to calcium channel blockers in idhiopathic
pulmonary arterial hipetension. Medscape. 2005;111(23): 3105-3111.
Available at http://www.medscape.com/medline/abstract/15939821
